Former USAA executive and San Antonio resident Dawn Johnson is currently focusing on her charitable affiliations. Dawn Johnson sits on the board of directors of both the San Antonio Clubhouse and the Leukemia & Lymphoma Society.

1. THE LEUKEMIA &
LYMPHOMA SOCIETY
BIOTECHNOLOGY
ACCELERATOR DIVISION
Dawn Johnson, San Antonio

2. Introduction
 Former USAA executive and San Antonio resident Dawn Johnson is
currently focusing on her charitable affiliations. Dawn Johnson sits
on the board of directors of both the San Antonio Clubhouse and
the Leukemia & Lymphoma Society.
The Leukemia & Lymphoma Society (LLS) fights against the blood
cancers that impact the lives of thousands of patients in America.
Most types of blood cancer are not preventable and are very difficult
to detect early. This makes finding cures for these life-threatening
conditions all the more important. LLS focuses on research areas
with specific unmet needs, and allocates funding to the most
promising research projects.
In addition to providing regular grants, the LLS Biotechnology
Accelerator Division works with leading biotechnology companies to
expedite the development of new therapies. It funds projects
including Celator Pharmaceuticals' CPX-351, also known as
VYXEOS. This therapy is in the third phase of clinical trials, and is
being evaluated for use in older patients with secondary Acute
Myeloid Leukemia.